In the last trading session, 1.18 million shares of the Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) were traded, and its beta was 0.01. Most recently the company’s share price was $7.68, and it changed around -$0.15 or -1.92% from the last close, which brings the market valuation of the company to $1.09B. MRVI currently trades at a discount to its 52-week high of $11.56, offering almost -50.52% off that amount. The share price’s 52-week low was $4.52, which indicates that the current value has risen by an impressive 41.15% since then. We note from Maravai LifeSciences Holdings Inc’s average daily trading volume that its 10-day average is 1.05 million shares, with the 3-month average coming to 2.06 million.
Maravai LifeSciences Holdings Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.60. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 6 rate it as Overweight. Among the rest, 4 recommended MRVI as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Maravai LifeSciences Holdings Inc is expected to report earnings per share of -0.01 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) trade information
Instantly MRVI has showed a red trend with a performance of -1.92% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 8.26 on recent trading dayincreased the stock’s daily price by 7.02%. The company’s shares are currently up 17.25% year-to-date, but still down -4.60% over the last five days. On the other hand, Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) is -13.42% down in the 30-day period. We can see from the shorts that 7.91 million shares have been sold at a short interest cover period of 2.93 day(s).
The consensus price target as assigned by Wall Street analysts is $22, which translates to bulls needing to increase their stock price by 65.09% from its current value. Analyst projections state that MRVI is forecast to be at a low of $10 and a high of $25.
Maravai LifeSciences Holdings Inc (MRVI) estimates and forecasts
Maravai LifeSciences Holdings Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -9.75 percent over the past six months and at a -166.67% annual growth rate that is well below the industry average of 12.30%. The year-over-year growth rate is expected to be -4.60%, down from the previous year.
Consensus estimates provided by 12 financial analysts predict the company will bring in an average of 67.55M in revenue for the current quarter. 12 analysts expect Maravai LifeSciences Holdings Inc to make 70.46M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 66.86M and 74.14M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 1.00%. Forecasts for the next quarter put sales growth at -5.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -37.53%. Maravai LifeSciences Holdings Inc earnings are expected to increase by -211.42% in 2024, but the outlook is positive 61.34% per year for the next five years.
MRVI Dividends
Maravai LifeSciences Holdings Inc’s next quarterly earnings report is expected to be released in November.
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.36% of Maravai LifeSciences Holdings Inc shares, and 105.58% of them are in the hands of institutional investors. The stock currently has a share float of 107.04%. Maravai LifeSciences Holdings Inc stock is held by 294.0 institutions, with GTCR LLC being the largest institutional investor. By 2024-06-30, it held 15.2267% of the shares, which is about 20.15 million shares worth $144.27 million.
12 WEST CAPITAL MANAGEMENT LP, with 9.9833% or 13.21 million shares worth $94.59 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
